Search Results - "Datoo MS"

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

Authors: Kibwana E Bundi C Kimani D et al.

Source: Frontiers in immunology [Front Immunol] 2025 Jul 07; Vol. 16, pp. 1620365. Date of Electronic Publication: 2025 Jul 07 (Print Publication: 2025).

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Authors: Kapulu MC Orenge F Kimani D et al.

Source: Nature medicine [Nat Med] 2026 Jan; Vol. 32 (1), pp. 178-185. Date of Electronic Publication: 2026 Jan 06.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.

Authors: Venkatraman N Silman D Bellamy D et al.

Source: The Lancet. Microbe [Lancet Microbe] 2025 Mar; Vol. 6 (3), pp. 100867. Date of Electronic Publication: 2025 Jan 10.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.

Authors: Venkatraman N Tiono AB Bowyer G et al.

Source: The Lancet. Microbe [Lancet Microbe] 2025 Mar; Vol. 6 (3), pp. 100868. Date of Electronic Publication: 2025 Jan 10.

Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

The R21/Matrix-M malaria vaccine: questions remain - Author's reply.

Authors: Datoo MS Hill AVS Beaumont E et al.

Source: Lancet (London, England) [Lancet] 2025 Jan 25; Vol. 405 (10475), pp. 299-301.

Publication Type: Letter

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process

Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria.

Authors: Noé A Datoo MS Flaxman A et al.

Source: Frontiers in immunology [Front Immunol] 2022 Feb 07; Vol. 13, pp. 795463. Date of Electronic Publication: 2022 Feb 07 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.

Authors: Schmit N Topazian HM Natama HM et al.

Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 May; Vol. 24 (5), pp. 465-475. Date of Electronic Publication: 2024 Feb 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Authors: Datoo MS Dicko A Tinto H et al.

Corporate Authors: Datoo MS Dicko A Tinto H et al.

Source: Lancet (London, England) [Lancet] 2024 Feb 10; Vol. 403 (10426), pp. 533-544. Date of Electronic Publication: 2024 Feb 01.

Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.

Authors: Sang S Datoo MS Otieno E et al.

Source: Wellcome open research [Wellcome Open Res] 2023 Oct 12; Vol. 8, pp. 450. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.

Authors: Datoo MS Natama HM Somé A et al.

Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Dec; Vol. 22 (12), pp. 1728-1736. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Mass administration of azithromycin reduces childhood mortality in Niger.

Authors: Murphy S Datoo MS

Source: Archives of disease in childhood. Education and practice edition [Arch Dis Child Educ Pract Ed] 2021 Oct; Vol. 106 (5), pp. 320. Date of Electronic Publication: 2020 Sep 08.

Publication Type: Journal Article; Comment

Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101220684 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-0593 (Electronic) Linking ISSN: 17430585 NLM ISO Abbreviation: Arch Dis Child Educ Pract Ed Subsets: MEDLINE

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Authors: Datoo MS Natama MH Somé A et al.

Source: Lancet (London, England) [Lancet] 2021 May 15; Vol. 397 (10287), pp. 1809-1818. Date of Electronic Publication: 2021 May 05.

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE